Objective: Bariatric surgery is an effective treatment for obesity, but it is unknown if outcomes differ between adults with early- versus adult-onset obesity. We investigated how obesity status at 20 years of age affects outcomes after bariatric surgery later in life.

Research Design And Methods: The Swedish Obese Subjects study is a prospective matched study performed at 25 surgical departments and 480 primary health care centers. Participants aged 37-60 years with BMI ≥34 kg/m (men) or ≥38 kg/m (women) were recruited between 1987 and 2001; 2,007 participants received bariatric surgery and 2,040 usual care. Self-reported body weight at 20 years of age was used to stratify patients into subgroups with normal BMI (<25 kg/m), overweight (BMI 25-29.9 kg/m), or obesity (BMI ≥30 kg/m). Body weight, energy intake, and type 2 diabetes status were examined over 10 years, and incidence of cardiovascular and microvascular disease was determined over up to 26 years using data from health registers.

Results: There were small but statistically significant differences in reduction of body weight among the subgroups after bariatric surgery (interaction = 0.032), with the largest reductions among those with obesity aged 20 years. Bariatric surgery increased type 2 diabetes remission (odds ratios 4.51, 4.90, and 5.58 in subgroups with normal BMI, overweight, or obesity at 20 years of age, respectively; interaction = 0.951), reduced type 2 diabetes incidence (odds ratios 0.15, 0.13, and 0.15, respectively; interaction = 0.972), and reduced microvascular complications independent of obesity status at 20 years of age (interaction = 0.650). The association between bariatric surgery and cardiovascular disease was similar in the subgroups (interaction = 0.674). Surgical complications were similar in the subgroups.

Conclusions: The treatment benefits of bariatric surgery in adults are similar regardless of obesity status at 20 years of age.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085812PMC
http://dx.doi.org/10.2337/dc19-1909DOI Listing

Publication Analysis

Top Keywords

bariatric surgery
16
adult-onset obesity
8
swedish obese
8
obese subjects
8
subjects study
8
years age
8
effects bariatric
4
surgery
4
surgery early-
4
early- adult-onset
4

Similar Publications

Background: The difference in survival between sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) remains controversial.

Objective: To investigate the comparative survival difference between SG and RYGB in adults with morbid obesity.

Setting: A meta-analysis.

View Article and Find Full Text PDF

2015 American Society for Metabolic and Bariatric Surgery Presidential address.

Surg Obes Relat Dis

November 2024

Yale Department of Surgery; New Haven, Connecticut. Electronic address:

View Article and Find Full Text PDF

Background: Metabolic bariatric surgery is the most effective therapy for severe obesity, which affects the health of millions, most of whom are women of child-bearing age. Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are the most common bariatric procedures and are associated with durable weight loss and comorbidity resolution. Although obstetric outcomes broadly improve, the safety profile comparing the impact of RYGB and SG on obstetric outcomes is underexplored.

View Article and Find Full Text PDF

Background: Robotic-assisted bariatric surgery is growing rapidly. The optimal approach to minimize complications remains unclear.

Objective: Assess robot utilization and compare 30-day outcomes for laparoscopic and robotic primary sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database.

View Article and Find Full Text PDF

Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis.

EBioMedicine

December 2024

Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Universitat Rovira i Virgili, Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; Department of Medicine and Surgery, Faculty of Medicine, Universitat Rovira i Virgili, Reus, Spain; The Campus of International Excellence Southern Catalonia, Tarragona, Spain. Electronic address:

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form steatohepatitis (MASH) contribute to rising morbidity and mortality rates. The storage of fat in humans is closely associated with these diseases' progression. Thus, adipose tissue metabolic homeostasis could be key in both the onset and progression of MASH.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!